A brief history of calcitonin.

作者信息

Colman Eric, Hedin Randy, Swann Joslyn, Orloff David

机构信息

Division of Metabolic and Endocrine Drug Products, US Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD 20857, USA.

出版信息

Lancet. 2002 Mar 9;359(9309):885-6. doi: 10.1016/S0140-6736(02)07949-7.

DOI:10.1016/S0140-6736(02)07949-7

PMID:11897305

Abstract

摘要

相似文献

A brief history of calcitonin.

Lancet. 2002 Mar 9;359(9309):885-6. doi: 10.1016/S0140-6736(02)07949-7.

Food and Drug Administration centennial: recognizing the guardians of our drug supply.

Arthritis Rheum. 2006 Oct;54(10):3374. doi: 10.1002/art.22144.

Drug development and FDA approval, 1938-2013.

N Engl J Med. 2014 Jun 26;370(26):e39. doi: 10.1056/NEJMp1402114.

Sure cure: public policy on drug efficacy before 1962.

Publ Am Inst Hist Pharm. 1997;16:223-61.

The pill at 40.

FDA Consum. 2000 Jul-Aug;34(4):36.

Food and Drug Administration Drug Approval Process: A History and Overview.

Nurs Clin North Am. 2016 Mar;51(1):1-11. doi: 10.1016/j.cnur.2015.10.007. Epub 2016 Jan 13.

Food and Drug Administration approval of laboratory tests.

Arch Pathol Lab Med. 2013 Jan;137(1):13-8. doi: 10.5858/arpa.2012-0077-ED.

Drug development history, "overview," and what are GCPs?

Qual Assur. 1995 Mar;4(1):75-9.

Déjà Vu at the FDA.

Milbank Q. 2017 Jun;95(2):245-248. doi: 10.1111/1468-0009.12252. Epub 2017 Apr 4.

Access before approval--a right to take experimental drugs?

N Engl J Med. 2006 Aug 3;355(5):437-40. doi: 10.1056/NEJMp068132.

引用本文的文献

Computational insights into the aggregation mechanism of human calcitonin.

Int J Biol Macromol. 2025 Mar;294:139520. doi: 10.1016/j.ijbiomac.2025.139520. Epub 2025 Jan 4.

Deciphering the influence of Y12L and N17H substitutions on the conformation and oligomerization of human calcitonin.

Soft Matter. 2024 Jan 17;20(3):693-703. doi: 10.1039/d3sm01332d.

Structural Perturbation of Monomers Determines the Amyloid Aggregation Propensity of Calcitonin Variants.

J Chem Inf Model. 2023 Jan 9;63(1):308-320. doi: 10.1021/acs.jcim.2c01202. Epub 2022 Dec 1.

Calcitonin (FORTICAL, MIACALCIN) for the treatment of vertebral compression fractures.

Orthop Rev (Pavia). 2021 Jun 21;13(2):24976. doi: 10.52965/001c.24976. eCollection 2021.

Inhibitory effects of magnolol and honokiol on human calcitonin aggregation.

Sci Rep. 2015 Sep 1;5:13556. doi: 10.1038/srep13556.

Osteoporosis: current trends in diagnosis and management.

Bosn J Basic Med Sci. 2006 Feb;6(1):24-8. doi: 10.17305/bjbms.2006.3205.

Interactions of the human calcitonin fragment 9-32 with phospholipids: a monolayer study.

Biophys J. 2004 Jul;87(1):386-95. doi: 10.1529/biophysj.103.036921.

Calcitonin and bone formation: a knockout full of surprises.

J Clin Invest. 2002 Dec;110(12):1769-71. doi: 10.1172/JCI17425.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

A brief history of calcitonin.

Lancet. 2002 Mar 9;359(9309):885-6. doi: 10.1016/S0140-6736(02)07949-7.

Food and Drug Administration centennial: recognizing the guardians of our drug supply.

Arthritis Rheum. 2006 Oct;54(10):3374. doi: 10.1002/art.22144.

Drug development and FDA approval, 1938-2013.

N Engl J Med. 2014 Jun 26;370(26):e39. doi: 10.1056/NEJMp1402114.

Sure cure: public policy on drug efficacy before 1962.

Publ Am Inst Hist Pharm. 1997;16:223-61.

The pill at 40.

FDA Consum. 2000 Jul-Aug;34(4):36.

Food and Drug Administration Drug Approval Process: A History and Overview.

Nurs Clin North Am. 2016 Mar;51(1):1-11. doi: 10.1016/j.cnur.2015.10.007. Epub 2016 Jan 13.

Food and Drug Administration approval of laboratory tests.

Arch Pathol Lab Med. 2013 Jan;137(1):13-8. doi: 10.5858/arpa.2012-0077-ED.

Drug development history, "overview," and what are GCPs?

Qual Assur. 1995 Mar;4(1):75-9.

Déjà Vu at the FDA.

Milbank Q. 2017 Jun;95(2):245-248. doi: 10.1111/1468-0009.12252. Epub 2017 Apr 4.

Access before approval--a right to take experimental drugs?

N Engl J Med. 2006 Aug 3;355(5):437-40. doi: 10.1056/NEJMp068132.

引用本文的文献

Computational insights into the aggregation mechanism of human calcitonin.

Int J Biol Macromol. 2025 Mar;294:139520. doi: 10.1016/j.ijbiomac.2025.139520. Epub 2025 Jan 4.

Deciphering the influence of Y12L and N17H substitutions on the conformation and oligomerization of human calcitonin.

Soft Matter. 2024 Jan 17;20(3):693-703. doi: 10.1039/d3sm01332d.

Structural Perturbation of Monomers Determines the Amyloid Aggregation Propensity of Calcitonin Variants.

J Chem Inf Model. 2023 Jan 9;63(1):308-320. doi: 10.1021/acs.jcim.2c01202. Epub 2022 Dec 1.

Calcitonin (FORTICAL, MIACALCIN) for the treatment of vertebral compression fractures.

Orthop Rev (Pavia). 2021 Jun 21;13(2):24976. doi: 10.52965/001c.24976. eCollection 2021.

Inhibitory effects of magnolol and honokiol on human calcitonin aggregation.

Sci Rep. 2015 Sep 1;5:13556. doi: 10.1038/srep13556.

Osteoporosis: current trends in diagnosis and management.

Bosn J Basic Med Sci. 2006 Feb;6(1):24-8. doi: 10.17305/bjbms.2006.3205.

Interactions of the human calcitonin fragment 9-32 with phospholipids: a monolayer study.

Biophys J. 2004 Jul;87(1):386-95. doi: 10.1529/biophysj.103.036921.

Calcitonin and bone formation: a knockout full of surprises.

J Clin Invest. 2002 Dec;110(12):1769-71. doi: 10.1172/JCI17425.